# ICCM (IceCure Medical Ltd.) - SEC EDGAR Financial Statements

> IceCure Medical Ltd. reported $3.38M in revenue and a net loss of $15.06M for the fiscal year ended December 31, 2025 (up 2.7% year over year), with a 36.3% gross margin and a -446.7% operating margin.

- Canonical: https://convexityos.com/fundamentals/ICCM
- Markdown: https://convexityos.com/fundamentals/ICCM.md
- SEC CIK: 0001584371
- Reporting currency: USD
- Latest filing period: December 31, 2025
- Last synced: Nov 21, 2026, 05:12 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001584371&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2025 | $3.38M | +2.7% YoY |
| Operating Income | FY 2025 | -$15.09M | -446.7% margin |
| Net Income | FY 2025 | -$15.06M | -445.6% net margin |
| Diluted EPS | FY 2025 | $0.24 | Split-adjusted |
| Free Cash Flow | FY 2025 | -$14.61M | -432.4% FCF margin |
| Cash & ST Investments | Dec 31, 2025 | $8.90M | Total debt: $230K |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $3.38M | $3.29M | $3.23M | $3.08M | $4.14M | $3.87M |
| Cost of Revenue | $2.15M | $1.84M | $1.93M | $1.64M | $1.94M | $1.42M |
| **Gross Profit** | $1.23M | $1.45M | $1.30M | $1.45M | $2.19M | $2.44M |
| Research & Development | $7.43M | $7.10M | $8.27M | $9.12M | $5.88M | $3.81M |
| Selling, General & Admin | $8.89M | $10.05M | $8.60M | $735K | $177K | $120K |
| **Operating Income** | -$15.09M | -$15.70M | -$15.58M | -$16.74M | -$9.72M | -$4.14M |
| **EBITDA** | -$14.80M | -$15.36M | -$15.25M | -$16.49M | -$9.60M | -$4.08M |
| **Net Income** | -$15.06M | -$15.32M | -$14.65M | -$16.98M | -$9.89M | -$3.73M |
| Basic EPS | $0.24 | $0.30 | $0.32 | $0.46 | $0.35 | $0.22 |
| **Diluted EPS** | $0.24 | $0.30 | $0.32 | $0.46 | $0.35 | $0.22 |
| Basic Shares Outstanding | 63.6M | 50.9M | 45.6M | 37.0M | 28.5M | 17.1M |
| Diluted Shares Outstanding | 63.6M | 50.9M | 45.6M | 37.0M | 28.5M | 17.1M |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $8.90M | $7.56M | $10.53M | $23.66M | $25.62M | $3.50M |
| Short-Term Investments | -- | -- | $529K | -- | -- | -- |
| **Cash & Short-Term Investments** | $8.90M | $7.56M | $11.06M | $23.66M | $25.62M | $3.50M |
| Accounts Receivable, Net | $331K | $221K | $103K | $78K | $456K | $94K |
| Inventory | $2.62M | $1.99M | $2.27M | $2.86M | $1.96M | $1.06M |
| **Total Current Assets** | $12.61M | $10.75M | $14.18M | $28.13M | $30.32M | $9.59M |
| Property, Plant & Equipment, Net | $993K | $1.25M | $1.51M | $1.36M | $713K | $307K |
| **Total Non-Current Assets** | $1.28M | $1.82M | $2.23M | $2.06M | $1.96M | $650K |
| **Total Assets** | $13.89M | $12.58M | $16.41M | $30.19M | $32.28M | $10.24M |
| Accounts Payable | $863K | $1.23M | $502K | $714K | $881K | $645K |
| Deferred Revenue (Current) | $255K | $334K | $187K | $646K | $884K | $1.38M |
| Other Current Liabilities | $1.10M | $1.23M | $3.15M | $3.46M | $2.92M | $2.85M |
| **Total Current Liabilities** | $4.82M | $5.51M | $3.87M | $4.34M | $4.02M | $3.71M |
| Long-Term Debt | $13K | $161K | -- | -- | -- | -- |
| **Total Non-Current Liabilities** | $13K | $161K | $376K | $430K | $1.30M | $877K |
| **Total Liabilities** | $4.84M | $5.67M | $4.25M | $4.77M | $5.32M | $4.59M |
| **Total Debt (incl. Leases)** | $230K | $620K | $599K | $597K | $909K | $332K |
| Retained Earnings | -$120.4M | -$105.4M | -$90.06M | -$75.41M | -$58.43M | -$48.54M |
| **Total Stockholders' Equity** | $9.05M | $6.90M | $12.16M | $25.42M | $26.96M | $5.65M |
| Total Equity | $9.05M | $6.90M | $12.16M | $25.42M | $26.96M | $5.65M |

### Balance Sheet (Quarterly)

| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $8.90M | $7.56M | $10.53M | $23.66M | $25.62M | $3.50M |
| Short-Term Investments | -- | -- | $529K | -- | -- | -- |
| **Cash & Short-Term Investments** | $8.90M | $7.56M | $11.06M | $23.66M | $25.62M | $3.50M |
| Accounts Receivable, Net | $331K | $221K | $103K | $78K | $456K | $94K |
| Inventory | $2.62M | $1.99M | $2.27M | $2.86M | $1.96M | $1.06M |
| **Total Current Assets** | $12.61M | $10.75M | $14.18M | $28.13M | $30.32M | $9.59M |
| Property, Plant & Equipment, Net | $993K | $1.25M | $1.51M | $1.36M | $713K | $307K |
| **Total Non-Current Assets** | $1.28M | $1.82M | $2.23M | $2.06M | $1.96M | $650K |
| **Total Assets** | $13.89M | $12.58M | $16.41M | $30.19M | $32.28M | $10.24M |
| Accounts Payable | $863K | $1.23M | $502K | $714K | $881K | $645K |
| Deferred Revenue (Current) | $255K | $334K | $187K | $646K | $884K | $1.38M |
| Other Current Liabilities | $1.10M | $1.23M | $3.15M | $3.46M | $2.92M | $2.85M |
| **Total Current Liabilities** | $4.82M | $5.51M | $3.87M | $4.34M | $4.02M | $3.71M |
| Long-Term Debt | $13K | $161K | -- | -- | -- | -- |
| **Total Non-Current Liabilities** | $13K | $161K | $376K | $430K | $1.30M | $877K |
| **Total Liabilities** | $4.84M | $5.67M | $4.25M | $4.77M | $5.32M | $4.59M |
| **Total Debt (incl. Leases)** | $230K | $620K | $599K | $597K | $909K | $332K |
| Retained Earnings | -$120.4M | -$105.4M | -$90.06M | -$75.41M | -$58.43M | -$48.54M |
| **Total Stockholders' Equity** | $9.05M | $6.90M | $12.16M | $25.42M | $26.96M | $5.65M |
| Total Equity | $9.05M | $6.90M | $12.16M | $25.42M | $26.96M | $5.65M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$15.06M | -$15.32M | -$14.65M | -$16.98M | -$9.89M | -$3.73M |
| Depreciation & Amortization | $295K | $332K | $323K | $248K | $127K | $63K |
| Stock-Based Compensation | $1.37M | $869K | $1.31M | $1.86M | $316K | $229K |
| Change in Receivables | -$110K | -$118K | -$25K | $378K | -$362K | -$77K |
| Change in Inventory | -$637K | $287K | $582K | -$902K | -$891K | -- |
| Change in Payables | -$369K | $730K | -$212K | -$167K | $236K | $217K |
| **Operating Cash Flow** | -$14.57M | -$12.56M | -$12.55M | -$14.29M | -$12.61M | -$3.69M |
| Capital Expenditure | -$36K | -$71K | -$480K | -$891K | -$533K | -$223K |
| **Free Cash Flow** | -$14.61M | -$12.63M | -$13.03M | -$15.18M | -$13.14M | -$3.91M |
| Purchases of Investments | -$5.00M | -$1.37M | -$500K | -- | -- | -- |
| **Investing Cash Flow** | -$36K | $446K | -$684K | -$891K | $3.79M | -$4.67M |
| Common Stock Issued | -- | $9.19M | -- | $13.57M | $14.59M | $5.85M |
| **Financing Cash Flow** | $15.83M | $9.19M | $83K | $13.58M | $30.89M | $5.86M |
| **Net Change in Cash** | $1.22M | -$2.93M | -$13.15M | -$1.61M | $22.08M | -$2.50M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| **Gross Margin** | 36.3% | 44.1% | 40.3% | 46.8% | 53.0% | 63.2% |
| **Operating Margin** | -446.7% | -476.9% | -482.4% | -542.6% | -235.0% | -107.1% |
| **Net Profit Margin** | -445.6% | -465.5% | -453.8% | -550.3% | -239.1% | -96.4% |
| Return on Equity (ROE) | -166.4% | -222.0% | -120.5% | -66.8% | -36.7% | -66.0% |
| Return on Assets (ROA) | -108.4% | -121.8% | -89.3% | -56.2% | -30.7% | -36.4% |
| Current Ratio | 2.61x | 1.95x | 3.66x | 6.49x | 7.54x | 2.58x |
| Quick Ratio | 2.07x | 1.59x | 3.08x | 5.83x | 7.06x | 2.30x |
| Debt to Equity | 0.03x | 0.09x | 0.05x | 0.02x | 0.03x | 0.06x |
| **Revenue Growth (YoY)** | +2.7% | +1.9% | +4.7% | -25.4% | +7.0% | -- |
| Gross Profit Growth (YoY) | -15.5% | +11.6% | -10.0% | -34.2% | -10.2% | -- |
| EPS Growth (YoY) | -20.0% | -6.3% | -30.4% | +31.4% | +59.1% | -- |
| 5Y Revenue / Share Growth | -76.5% | -- | -- | -- | -- | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
